研究报告

25个携带线粒体12S rRNA A1555G突变的中国汉族非综合征型耳聋家系

展开
  • 1. 温州医学院附属第二医院 附属育英儿童医院耳鼻喉科, 温州 325027; 2. 余姚市人民医院耳鼻咽喉科, 宁波 315400; 3. 温州医学院Attardi线粒体生物医学研究院和浙江省医学遗传学重点实验室, 温州 325035; 4. 温州医学院附属第一医院耳鼻喉科, 温州 325027; 5. 浙江大学生命科学学院, 杭州 310058

收稿日期: 2012-04-10

  修回日期: 2012-10-29

  网络出版日期: 2013-01-25

基金资助

国家重点基础研究发展计划项目(973计划)(编号:2004CCA02200), 国家自然科学基金项目(编号:81070794), 国家青年科学基金项目(编号:31100903),浙江省重大科技专项社会发展项目(编号:2007C13021), 浙江省自然基金项目(编号:Y2110399), 浙江省自然基金项目(编号:Y12H130007), 浙江省卫生厅项目(编号:2009A135), 浙江省研究生创新科研项目(编号:YK2010084)和温州市瓯海区科技计划项目(编号:2011XM047)资助

Mitochondrial 12S rRNA A1555G mutation associated with nonsyn-dromic hearing loss in twenty-five Han Chinese pedigrees

Expand
  • 1. Department of Otolaryngology, the Second Affiliated Hospital & Yuying Children’s Hospital of Wenzhou Medical College, Wenzhou 325027, China; 2. Department of Otolaryngology, Yuyao People’s Hospital, Ningbo 315400, China; 3. Attardi Institute of Mitochondrial Biomedicine and Zhejiang Provincial Key Laboratory of Medical Genetics, School of Life Sciences, Wenzhou Medical College, Wenzhou 325035, China; 4. Department of Otolaryngology, the First Affiliated Hospital of Wenzhou Medical College, Wenzhou 325027, China; 5. College of Life Sciences, Zhejiang University, Hangzhou 310058, China

Received date: 2012-04-10

  Revised date: 2012-10-29

  Online published: 2013-01-25

摘要

线粒体12S rRNA A1555G突变是引起氨基糖甙类药物诱导的非综合征型耳聋的重要原因之一。文章对收集的25个携带A1555G突变的中国汉族非综合征型耳聋家系进行了临床和分子遗传学评估。结果表明, 这25个家系的母系成员在耳聋外显率、听力损失严重程度和发病年龄上存在较大差异。当包括和不包括氨基糖甙类药物使用史时, 耳聋的平均外显率分别为28.1%和21.5%, 排除氨基糖甙类药物时, 耳聋的平均发病年龄从1~15岁不等。线粒体全序列分析发现了16个新变异, 不同的线粒体DNA多态性位点显示这25个家系分别属于东亚人群A、B、D、F、G、M、N和R单倍型, 其中线粒体单倍型B的家系耳聋外显率和表现度较其他单倍型高。此外, 7个继发突变位点和21个高保守性位点突变可能增加了这些家系的耳聋外显率。GJB2基因上未检测到与耳聋相关的突变, 表明在本研究的耳聋家系中, GJB2基因可能没有参与A1555G突变的表型表达。以上各方面提示, 线粒体单倍型和其他因素可能参与了这25个家系耳聋患者的表型修饰。

本文引用格式

彭光华,郑斌娇,方芳,伍越,梁玲芝,郑静,南奔宇,余啸,唐霄雯,朱翌,吕建新,陈波蓓,管敏鑫 . 25个携带线粒体12S rRNA A1555G突变的中国汉族非综合征型耳聋家系[J]. 遗传, 2013 , 35(1) : 62 -72 . DOI: 10.3724/SP.J.1005.2013.00062

Abstract

Mitochondrial 12S rRNA A1555AG mutation is one of the important causes of aminoglycoside-induced and nonsyndromic deafness. We report here the cilinical, genetic and molecular characterization of 25 Chinese families carrying the A1555G mutation.Clinical and genetic characterizations of these Chinese families exhibited a wide range of penetrance, severity and age-at-onset of hearing impairment. The average penetrances of deafness were 28.1% and 21.5%, respectively, when aminoglycoside-induced hearing loss was included or excluded. Furthermore, the average age-of-onset for deafness without aminoglycoside exposure ranged from 1 and 15 years old. Their mitochondrial genomes exhibited distinct sets of polymorphisms including 16 novel variants, belonging to ten Eastern Asian haplogroups A, B, D, F, G, M, N and R, respec-tively. Strikingly, these Chinese families carrying mitochondrial haplogroup B exhibited higher penetrance and expressivity of hearing loss. In addition, 7 known secondary mutations and 21 variants resided at the highly conservative residues may enhance the penetrace of hearing loss in these Chinese families. Moreover, the absence of mutation in GJB2 gene suggested that GJB2 may not be a modifier for the phenotypic expression of the A1555G mutation in these Chinese families. These observations suggested that mitochondrial haplotypes and other modifiers may modulate the variable pene-trance and expressivity of deafness among these Chinese families.

参考文献

[1] Prezant TR, Agapian JV, Bohlman MC, Bu XD, Öztas S, Qiu WQ, Arnos KS, Cortopassi GA, Jaber L, Rotter JI, Shohat M, Fischel-Ghodsian N. Mitochondrial ribosomal RNA mutation associated with both antibiotic-induced and non-syndromic deafness. Nat Genet, 1993, 4(3): 289-294.
[2] Li R, Greinwald JH, Yang L, Choo DI, Wenstrup RJ, Guan MX. Molecular analysis of the mitochondrial 12S rRNA and tRNASer(UCN) genes in paediatric subjects with non-syndromic hearing loss. J Med Genet, 2004, 41(8): 615-620.
[3] Li R, Xing GQ, Yan M, Cao X, Liu XZ, Bu XK, Guan MX. Cosegregation of C-insertion at position 961 with the A1555G mutation of the mitochondrial 12S rRNA gene in a large Chinese family with maternally inherited hearing loss. Am J Med Genet A, 2004, 124A(2): 113-117.
[4] del Castillo FJ, Rodríguez-Ballesteros M, Martín Y, Arellano B, Gallo-Terán J, Morales-Angulo C, Ramírez- Camacho R, Cruz Tapia M, Solaneltas J, Martínez-Conde A, Villamar M, Moreno-Pelayo MA, Moreno F, del Castillo I. Heteroplasmy for the 1555A>G mutation in the mitochondrial 12S rRNA gene in six Spanish families with non-syndromic hearing loss. J Med Genet, 2003, 40(8): 632-636.
[5] Young WY, Zhao L, Qian Y, Wang Q, Li N, Greinwald JH Jr, Guan MX. Extremely low penetrance of hearing loss in four Chinese families with the mitochondrial 12S rRNA A1555G mutation. Biochem Biophys Res Commun, 2005, 328(4): 1244-1251.
[6] Yuan H, Qian Y, Xu Y, Cao J, Bai L, Shen W, Ji F, Zhang X, Kang D, Mo JQ, Greinwald JH, Han D, Zhai S, Young WY, Guan MX. Cosegregation of the G7444A mutation in the mitochondrial COI/tRNASer(UCN) genes with the 12S rRNA A1555G mutation in a Chinese family with aminoglycoside-induced and non-syndromic hearing loss. Am J Med Genet A, 2005, 138A(2): 133-140.
[7] Jacobs HT, Hutchin TP, Käppi T, Gillies G, Minkkinen K, Walker J, Thompson K, Rovio AT, Carella M, Melchionda S, Zelante L, Gasparini P, Pyykkö I, Shah ZH, Zeviani M, Mueller RF. Mitochondrial DNA mutations in patients with postlingual, nonsyndromic hearing impairment. Eur J Hum Genet, 2005, 13(1): 26-33.
[8] 赵立东, 王秋菊, 郭维维, 管敏鑫, 韩东一, 杨伟炎. 与线粒体DNA A1555G突变有关的非综合征型耳聋. 中华耳科学杂志, 2004, 2(2): 136-141.
[9] Wang QJ, Li QZ, Han DY, Zhao YL, Zhao LD, Qian YP, Yuan H, Li RH, Zhai SQ, Young WY, Guan MX. Clinical and molecular analysis of a four-generation Chinese fam-ily with aminoglycoside-induced and nonsyndromic hear-ing loss associated with the mitochondrial 12S rRNA C1494T mutation. Biochem Biophys Res Commun, 2006, 340(2): 583-588.
[10] Rodríguez-Ballesteros M, Olarte M, Aguirre LA, Galán F, Galán R, Vallejo LA, Navas C, Villamar M, Moreno- Pelayo MA, Moreno F, del Castillo I. Molecular and clinical characterisation of three Spanish families with maternally inherited non-syndromic hearing loss caused by the 1494C→T mutation in the mitochondrial 12S rRNA gene. J Med Genet, 2006, 43(11): e54.
[11] Chen J, Yang L, Yang A, Zhu Y, Zhao J, Sun D, Tao Z, Tang X, Wang J, Wang X, Tsushima A, Lan J, Li W, Wu F, Yuan Q, Ji J, Feng J, Wu C, Liao Z, Li Z, Greinwald JH, Lu J, Guan MX. Maternally inherited aminoglycoside-induced and nonsyndromic hearing loss is associated with the 12S rRNA C1494T mutation in three Han Chinese pedigrees. Gene, 2007, 401(1-2): 4-11.
[12] Estivill X, Govea N, Barceló E, Badenas C, Romeró E, Moral L, Scozzri R, D'Urbano L, Zeviani M, Torroni A. Familial progressive sensorineural deafness is mainly due to the mtDNA A1555G mutation and is enhanced by treatment with aminoglycosides. Am J Hum Genet, 1998, 62(1): 27-35.
[13] 张婷, 陈波蓓, 郑静, 龚莎莎, 张初琴, 吕建新, 管敏鑫. 五个母系遗传非综合征性耳聋和药物性耳聋的中国汉族家系. 中华医学遗传学杂志, 2011, 28(4): 367-373.
[14] Chen B, Sun D, Yang L, Zhang C, Yang A, Zhu Y, Zhao J, Chen Y, Guan M, Wang X, Li R, Tang X, Wang J, Tao Z, Lu
文章导航

/